Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...
The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant Duloxetine for potentially cancer-causing chemicals in the medication.
Thousands of bottles of a popular antidepressant medication are being recalled due ... Towa Pharmaceutical Europe referred ABC News to the FDA's website on nitrosamine impurities in medications.
Thousands of bottles of the antidepressant duloxetine ... according to a notice from the Food and Drug Administration. The October 10 recall is due to the presence of N-nitroso-duloxetine ...
NEW YORK (PIX11) – The Federal Drug Administration issued a recall on Tuesday for a common medicine for depression. Over 7,000 bottles of Duloxetine were recalled due to the elevated presence of ...
During pregnancy, a health care provider will generally need to manage two different clinical scenarios: 1) starting medications, either for a woman with new-onset depression or for a woman ...